FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140167108> ?p ?o ?g. }

• W2140167108 abstract "Adverse drug reactions (ADRs) contribute to ill-health or life-threatening outcomes of therapy during management of infectious diseases. The exposure to anti-malarial and use of mobile phone technology to report ADRs following drug exposures were investigated in Sagamu - a peri-urban community in Southwest Nigeria. Purchase of medicines was actively monitored for 28 days in three Community Pharmacies (CP) and four Patent and Proprietary Medicine Stores (PPMS) in the community. Information on experience of ADRs was obtained by telephone from 100 volunteers who purchased anti-malarials during the 28-day period. A total of 12,093 purchases were recorded during the period. Antibiotics, analgesics, vitamins and anti-malarials were the most frequently purchased medicines. A total of 1,500 complete courses of anti-malarials were purchased (12.4% of total purchases); of this number, purchases of sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) were highest (39.3 and 25.2% respectiuvely). Other anti-malarials purchased were artesunate monotherapy (AS) - 16.1%, artemether-lumefantrine (AL) 10.0%, amodiaquine (AQ) - 6.6%, quinine (QNN) - 1.9%, halofantrine (HF) - 0.2% and proguanil (PR) - 0.2%. CQ was the cheapest (USD 0.3) and halofantrine the most expensive (USD 7.7). AL was 15.6 times ($4.68) more expensive than CQ. The response to mobile phone monitoring of ADRs was 57% in the first 24 hours (day 1) after purchase and decreased to 33% by day 4. Participants in this monitoring exercise were mostly with low level of education (54%). The findings from this study indicate that ineffective anti-malaria medicines including monotherapies remain widely available and are frequently purchased in the study area. Cost may be a factor in the continued use of ineffective monotherapies. Availability of a toll-free telephone line may facilitate pharmacovigilance and follow up of response to medicines in a resource-poor setting." @default.
• W2140167108 created "2016-06-24" @default.
• W2140167108 creator A5000303753 @default.
• W2140167108 creator A5002602444 @default.
• W2140167108 creator A5007359820 @default.
• W2140167108 creator A5010982870 @default.
• W2140167108 creator A5024426508 @default.
• W2140167108 creator A5035934464 @default.
• W2140167108 creator A5048035758 @default.
• W2140167108 creator A5052222497 @default.
• W2140167108 creator A5069564359 @default.
• W2140167108 creator A5075988406 @default.
• W2140167108 creator A5077707770 @default.
• W2140167108 creator A5077989122 @default.
• W2140167108 creator A5088840175 @default.
• W2140167108 date "2011-08-09" @default.
• W2140167108 modified "2023-10-15" @default.
• W2140167108 title "Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance" @default.
• W2140167108 cites W1812263859 @default.
• W2140167108 cites W1992227904 @default.
• W2140167108 cites W2018893332 @default.
• W2140167108 cites W2031796122 @default.
• W2140167108 cites W2053040393 @default.
• W2140167108 cites W2113576593 @default.
• W2140167108 cites W2131535940 @default.
• W2140167108 cites W2136473603 @default.
• W2140167108 cites W2139177540 @default.
• W2140167108 cites W2148446039 @default.
• W2140167108 cites W2163483188 @default.
• W2140167108 cites W2167410605 @default.
• W2140167108 cites W2186781028 @default.
• W2140167108 cites W3122763283 @default.
• W2140167108 cites W47970597 @default.
• W2140167108 doi "https://doi.org/10.1186/1475-2875-10-230" @default.
• W2140167108 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3162590" @default.
• W2140167108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21827667" @default.
• W2140167108 hasPublicationYear "2011" @default.
• W2140167108 type Work @default.
• W2140167108 sameAs 2140167108 @default.
• W2140167108 citedByCount "22" @default.
• W2140167108 countsByYear W21401671082012 @default.
• W2140167108 countsByYear W21401671082013 @default.
• W2140167108 countsByYear W21401671082014 @default.
• W2140167108 countsByYear W21401671082015 @default.
• W2140167108 countsByYear W21401671082016 @default.
• W2140167108 countsByYear W21401671082017 @default.
• W2140167108 countsByYear W21401671082018 @default.
• W2140167108 countsByYear W21401671082019 @default.
• W2140167108 countsByYear W21401671082020 @default.
• W2140167108 countsByYear W21401671082022 @default.
• W2140167108 countsByYear W21401671082023 @default.
• W2140167108 crossrefType "journal-article" @default.
• W2140167108 hasAuthorship W2140167108A5000303753 @default.
• W2140167108 hasAuthorship W2140167108A5002602444 @default.
• W2140167108 hasAuthorship W2140167108A5007359820 @default.
• W2140167108 hasAuthorship W2140167108A5010982870 @default.
• W2140167108 hasAuthorship W2140167108A5024426508 @default.
• W2140167108 hasAuthorship W2140167108A5035934464 @default.
• W2140167108 hasAuthorship W2140167108A5048035758 @default.
• W2140167108 hasAuthorship W2140167108A5052222497 @default.
• W2140167108 hasAuthorship W2140167108A5069564359 @default.
• W2140167108 hasAuthorship W2140167108A5075988406 @default.
• W2140167108 hasAuthorship W2140167108A5077707770 @default.
• W2140167108 hasAuthorship W2140167108A5077989122 @default.
• W2140167108 hasAuthorship W2140167108A5088840175 @default.
• W2140167108 hasBestOaLocation W21401671081 @default.
• W2140167108 hasConcept C104863432 @default.
• W2140167108 hasConcept C197934379 @default.
• W2140167108 hasConcept C203014093 @default.
• W2140167108 hasConcept C2776120307 @default.
• W2140167108 hasConcept C2776992834 @default.
• W2140167108 hasConcept C2777199930 @default.
• W2140167108 hasConcept C2777425658 @default.
• W2140167108 hasConcept C2777498558 @default.
• W2140167108 hasConcept C2778048844 @default.
• W2140167108 hasConcept C2778059366 @default.
• W2140167108 hasConcept C2778118209 @default.
• W2140167108 hasConcept C2778371730 @default.
• W2140167108 hasConcept C2780780316 @default.
• W2140167108 hasConcept C2781160685 @default.
• W2140167108 hasConcept C512399662 @default.
• W2140167108 hasConcept C57658597 @default.
• W2140167108 hasConcept C71924100 @default.
• W2140167108 hasConcept C98274493 @default.
• W2140167108 hasConcept C99454951 @default.
• W2140167108 hasConceptScore W2140167108C104863432 @default.
• W2140167108 hasConceptScore W2140167108C197934379 @default.
• W2140167108 hasConceptScore W2140167108C203014093 @default.
• W2140167108 hasConceptScore W2140167108C2776120307 @default.
• W2140167108 hasConceptScore W2140167108C2776992834 @default.
• W2140167108 hasConceptScore W2140167108C2777199930 @default.
• W2140167108 hasConceptScore W2140167108C2777425658 @default.
• W2140167108 hasConceptScore W2140167108C2777498558 @default.
• W2140167108 hasConceptScore W2140167108C2778048844 @default.
• W2140167108 hasConceptScore W2140167108C2778059366 @default.
• W2140167108 hasConceptScore W2140167108C2778118209 @default.
• W2140167108 hasConceptScore W2140167108C2778371730 @default.
• W2140167108 hasConceptScore W2140167108C2780780316 @default.
• W2140167108 hasConceptScore W2140167108C2781160685 @default.
• W2140167108 hasConceptScore W2140167108C512399662 @default.

• next